Ron Kamienchick is a senior director at Teva Pharmaceutical’s Digital Health group, responsible for AI and Analytic Products.
In the past 16 years, Ron has held a wide range of commercial roles in the personalized healthcare space, in both startups and global pharmaceutical companies.
During his 5 years at Teva, Ron has led multiple projects involving complimentary and companion diagnostics, wearables, 3D printing, and AI.
In his current role, Ron is the product owner for Teva’s Machine Learning initiative in the respiratory space, focused on the development and strategy of a predictive model for asthma and COPD exacerbations.
- Keeping up with the Digital Health Revolution
- Tuesday, February 11 • 9:45 AM - 10:30 AM
- Are AI-Powered Devices Really the Future for Healthcare?
- Tuesday, February 11 • 4:05 PM - 5:00 PM